Skip to main content
. 2023 Mar 15;14:1129753. doi: 10.3389/fimmu.2023.1129753

Figure 4.

Figure 4

(A) Anti-S-RBD IgG and (B) neutralizing antibody titers one month (T3) after the third mRNA vaccine dose according to the group of participants (IR, immune responders. DIR, discordant immune responders) and the vaccine received.